Skip to main content

Table 1 Baseline characteristics of ICU patients with Candida BSI

From: Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study

  Inappropriate (n = 80) Appropriate (n = 10) P value*
Age 57.2 ± 16.5 55.1 ± 21.8 0.774
Gender (Female) 38 (47.5%) 6 (60.0%) 0.518
Race (African American) 22 (27.5%) 4 (40.0%) 0.466
Medical service 50 (62.5%) 10 (100%) 0.027
CBSI on admission 18 (22.5%) 10 (100%) <0.001
Comorbidities    
   CHF 18 (22.5%) 3 (30.0%) 0.693
   CAD 19 (23.8%) 4 (40.0%) 0.270
   DM 25 (31.3%) 4 (40.0%) 0.721
   COPD 16 (20.0%) 1 (10.0%) 0.680
   Liver disease 4 (5.0%) 0 1.000
   ESRD 7 (8.8%) 2 (20.0%) 0.261
   HIV 1 (1.3%) 0 1.000
   Cancer 23 (28.8%) 2 (20.0%) 0.720
   Organ transplant 1 (1.3%) 1 (10.0%) 0.218
APACHE II score 16.3 ± 6.7 16.3 ± 7.8 0.990
MV 52 (65.0%) 6 (60.0%) 0.739
Pressors 23 (28.8%) 4 (40.0%) 0.479
CVC present 70 (87.5%) 8 (80.0%) 0.617
  1. *P values derived using Student's t-test for continuous and Fisher's exact test for categorical variables